Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-24
2011-05-24
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S388000, C514S045000, C514S395000, C514S248000, C546S123000, C546S118000, C548S306400, C544S236000
Reexamination Certificate
active
07947709
ABSTRACT:
Compounds of formula I, wherein R1, R2, R3, X and Ar, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula I useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.
REFERENCES:
patent: 7166738 (2007-01-01), Dunn et al.
patent: 7189718 (2007-03-01), Dunn et al.
patent: 7208509 (2007-04-01), Dunn et al.
patent: 2005/0215554 (2005-09-01), Dunn et al.
patent: 2005/0239880 (2005-10-01), Dunn et al.
patent: 2006/0025462 (2006-02-01), Dunn et al.
patent: 2006/0069261 (2006-03-01), Bonneau et al.
patent: 2006/0223874 (2006-10-01), Martin et al.
patent: 2007/0078128 (2007-04-01), Saito et al.
patent: 2007/0088015 (2007-04-01), Silva et al.
patent: 2007/0088053 (2007-04-01), Mirzadegan et al.
patent: 2008/0020981 (2008-01-01), Sweeney
patent: WO 02/04424 (2002-01-01), None
patent: WO 02/085860 (2002-10-01), None
patent: WO 02/100853 (2002-12-01), None
patent: WO 2004/029042 (2004-04-01), None
patent: WO 2004/029051 (2004-04-01), None
patent: WO 2004/031178 (2004-04-01), None
patent: WO 2006014136 (2006-02-01), None
patent: WO 2006/067587 (2006-06-01), None
patent: WO 2006/067587 (2006-06-01), None
patent: WO 2007/015809 (2007-02-01), None
patent: WO 2008/009613 (2008-01-01), None
Wikipedia, treating HIV and AIDS—2010—p. 1-2.
Chan, J. H., wt. al. “Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1,”J. Med. Chem.2004, vol. 47, pp. 1175-1182.
Genin M. J., et. al. Novel 1,5-Diphenylpyrazole Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant : Lead Identification and SAR of 3- and 4-Substituted Derivatives,J. Med. Chem.2000, vol. 43, pp. 1034-1040.
Romines, K. R. et. al. “Structure-Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Non-nucleoside Reverse Transcriptase Inhibitors,”J. Med. Chem.2006, vol. 49, pp. 727-739.
Wyatt, P. G., et. al. Benzophenone Derivatives : A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase,J. Med. Chem.1995 vol. 38, pp. 1657-1665.
Elworthy Todd Richard
Hogg Joan Heather
Kennedy-Smith Joshua
O'Yang Counde
Smith Mark
Buckwalter Brian L.
Chu Yong
Roche Palo Alto LLC
LandOfFree
Non-nucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-nucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-nucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2704562